We only have this paper's title and publication details.
Read it at the sourceHigh-throughput screening reveals 100 significant emergent biomarkers in pan-cancer cell lines, highlighting candidate targets for combination therapy.
Supplementary Table 14 shows the top 100 significant emergent biomarkers
No takes yet. Share an insight, caveat, or question.
Bashi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: